NCT07190300
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07190300
Title TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC) (TulmiSTAR-02)
Acronym TulmiSTAR-02
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | TUR | ITA | HUN | GBR | FRA | ESP | DEU | CAN | BRA | AUS

Facility Status City State Zip Country Details
Univ of Alabama at Birmingham RECRUITING Birmingham Alabama 35294-3300 United States Details
Uni Of Iowa Hospitals And Clinics RECRUITING Iowa City Iowa 52242 United States Details
University of Kansas Cancer Center RECRUITING Westwood Kansas 66205 United States Details
Wichita Urology Group PA RECRUITING Wichita Kansas 67226 United States Details
Duke University Medical Center RECRUITING Durham North Carolina 27710 United States Details
Medical University of South Carolina MUSC RECRUITING Charleston South Carolina 29425 United States Details
Carolina Urologic Research Center RECRUITING Myrtle Beach South Carolina 29572 United States Details
Huntsman Cancer Institute RECRUITING Salt Lake City Utah 84112 United States Details
Novartis Investigative Site WITHDRAWN Camperdown New South Wales 2050 Australia Details
Novartis Investigative Site RECRUITING Wollongong New South Wales 2500 Australia Details
Novartis Investigative Site RECRUITING Porto Alegre Rio Grande do Sul 90610-001 Brazil Details
Novartis Investigative Site RECRUITING Montreal Quebec H2X 1R9 Canada Details
Novartis Investigative Site RECRUITING Guangzhou 510060 China Details
Novartis Investigative Site RECRUITING Créteil 94010 France Details
Novartis Investigative Site RECRUITING Lille 59020 France Details
Novartis Investigative Site RECRUITING Nantes 44093 France Details
Novartis Investigative Site RECRUITING Jena Thuringia 07740 Germany Details
Novartis Investigative Site RECRUITING Essen 45147 Germany Details
Novartis Investigative Site RECRUITING Hong Kong 999077 Hong Kong Details
Novartis Investigative Site RECRUITING Budapest H 1122 Hungary Details
Novartis Investigative Site RECRUITING Budapest H-1083 Hungary Details
Novartis Investigative Site RECRUITING Szeged 6725 Hungary Details
Novartis Investigative Site RECRUITING Rozzano MI 20089 Italy Details
Novartis Investigative Site RECRUITING Verona VR 37134 Italy Details
Novartis Investigative Site RECRUITING Seoul 05505 South Korea Details
Novartis Investigative Site RECRUITING Seoul 06591 South Korea Details
Novartis Investigative Site RECRUITING Madrid 28034 Spain Details
Novartis Investigative Site RECRUITING Madrid 28040 Spain Details
Novartis Investigative Site RECRUITING Madrid 28222 Spain Details
Novartis Investigative Site RECRUITING Ankara Sihhiye-Altindag 06230 Turkey (Türkiye) Details
Novartis Investigative Site RECRUITING London W1G 6AD United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field